The eSource Company
| Features & Benefits | Example | ||
SYSTEM |
|||
 |
Multiple Language Support | A device at one site may support more than one language (including Japanese, Hebrew, Indian, and more) | |
| Exit/Save/Resume | Allow patient to Exit, Save, & Resume during long visits with many questionnaires | ||
| Instant Data Transmission | Allows study team to immediately review entries, track patient progress, etc. | ||
| Large, bright, crisp screen | Easy to see buttons/images, read text, and use Tablet, regardless of experience and age. | ||
| Supports varying requirements for different site visits | The system can support varying questionnaires based on site visit, etc. | ||
IMPROVED DATA QUALITY |
|||
 |
Accuracy | Checks data upon entry for format, range, type and allowable values | |
| Completeness | Ensures data fields are complete/questions are answered | ||
| Consistency | Data collection is consistent across all users and countries | ||
COST SAVINGS |
|||
 |
Monitoring Costs Decrease | Eliminate Source Data Verification | |
| No Data Entry from Paper | Eliminate Transcription Costs & Errors | ||
| Significantly Reduce Queries | Lower Costs & Study Team time | ||
| Labor Costs Reduced | No Printing, Proofing, Distribution, etc. | ||
According to the FDA guidance on source data in electronic form, eSource will help to eliminate unnecessary duplication of data, reduce the opportunity for transcription errors, promote the real-time entry of electronic source data during subject visits, ensure the accuracy and completeness of data, and more.
| assisTek's TotalSource solutions capture these improvements to source data, and are customized to each individual protocol. | More Information |
assisTek successfully fuses new developments in mobile technology with creative software solutions to revolutionize the collection of data from patients and clinicians in clinical trials. We have proudly been helping clinical trial teams achieve success for over 18 years, in 40 countries with 46 languages. Our expertise can support studies in any phase.
More Information
